DWA
FLGT icon

Dorsey Wright & Associates’s Fulgent Genetics FLGT Stock Holding History

Dorsey Wright & Associates’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-892
Closed -$12K – 299
2019
Q4 		$12K Buy
+892
New +$10.6K ﹤0.01% 192

Other funds holding FLGT

CFW
CA Family Wealth Beverly Hills, California $94.9M AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dorsey Wright & Associates's FLGT Position: Q1 2020 in Review

Dorsey Wright & Associates sold out of Fulgent Genetics (FLGT) in Q1 2020, closing a stake of 892 shares — an estimated $12K sold.

Dorsey Wright & Associates first reported a position in FLGT in Q4 2019 and held it in 1 quarter. The position peaked at $12K in Q4 2019. 75 funds tracked by Wall St. Rank hold FLGT as of Q1 2020.

  • Dorsey Wright & Associates reported no remaining Fulgent Genetics position as of Q1 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 892 Fulgent Genetics shares in Q1 2020, an estimated $12K.
  • Dorsey Wright & Associates first reported a position in Fulgent Genetics in Q4 2019 and held it in 1 quarter.
  • Dorsey Wright & Associates's Fulgent Genetics position peaked at $12K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2020.

Based on Dorsey Wright & Associates's 13F filing for Q1 2020, filed 20 Apr 2020.